You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-T-Cell Leukemia/lymphoma 1A (TCL1A) Antibodies

Full name:
anti-T-Cell Leukemia/lymphoma 1A Antibodies (TCL1A)
On are 93 T-Cell Leukemia/lymphoma 1A (TCL1A) Antibodies from 18 different suppliers available. Additionally we are shipping T-Cell Leukemia/lymphoma 1A Proteins (19) and T-Cell Leukemia/lymphoma 1A Kits (2) and many more products for this protein. A total of 123 T-Cell Leukemia/lymphoma 1A products are currently listed.
Tcl1, Tcl1a
list all antibodies Gene Name GeneID UniProt
TCL1A 21432 P56280
TCL1A 8115 P56279
TCL1A 690575  

Show all species

Show all synonyms

Most Popular Reactivities for anti-T-Cell Leukemia/lymphoma 1A (TCL1A) Antibodies

Select your species and application

anti-Mouse (Murine) Antibodies:

anti-Human Antibodies:

anti-Rat (Rattus) Antibodies:

All available anti-T-Cell Leukemia/lymphoma 1A Antibodies

Go to our pre-filtered search.

Top referenced anti-T-Cell Leukemia/lymphoma 1A Antibodies

  1. Human Monoclonal TCL1A Primary Antibody for IHC (fro), IHC (p) - ABIN1109210 : Rodig, Vergilio, Shahsafaei, Dorfman: Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation. in The American journal of surgical pathology 2007 (PubMed)
    Show all 7 references for ABIN1109210

  2. Human Monoclonal TCL1A Primary Antibody for FACS - ABIN2663891 : Laine, Künstle, Obata, Sha, Noguchi: The protooncogene TCL1 is an Akt kinase coactivator. in Molecular cell 2000 (PubMed)
    Show all 7 references for ABIN2663891

  3. Human Monoclonal TCL1A Primary Antibody for FACS - ABIN2658007 : Noguchi, Ropars, Roumestand, Suizu: Proto-oncogene TCL1: more than just a coactivator for Akt. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007 (PubMed)
    Show all 7 references for ABIN2658007

  4. Human Polyclonal TCL1A Primary Antibody for WB - ABIN1944776 : Virgilio, Narducci, Isobe, Billips, Cooper, Croce, Russo: Identification of the TCL1 gene involved in T-cell malignancies. in Proceedings of the National Academy of Sciences of the United States of America 1995 (PubMed)
    Show all 4 references for ABIN1944776

  5. Mouse (Murine) Polyclonal TCL1A Primary Antibody for ELISA, WB - ABIN190822 : Shen, Ferguson, Renard, Hoyer, Kim, Hao, Alt, Roeder, Morse, Teitell: Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation. in Blood 2006 (PubMed)

  6. Human Polyclonal TCL1A Primary Antibody for WB - ABIN2787835 : Herling, Patel, Teitell, Konopleva, Ravandi, Kobayashi, Jones: High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia. in Blood 2007 (PubMed)

More Antibodies against T-Cell Leukemia/lymphoma 1A Interaction Partners

Mouse (Murine) T-Cell Leukemia/lymphoma 1A (TCL1A) interaction partners

  1. results indicate that decreased Cav-1 (show CAV1 Antibodies) in Emu-TCL1 mice significantly delays the onset of CLL and decreases leukemic progression by inhibiting MAPK-Erk (show MAPK1 Antibodies) signaling, suggesting a role for Cav-1 (show CAV1 Antibodies) in the proliferation and progression of CLL

  2. This review discusses the main features of the original TCL1 models and the different lines of research successively developed with particular attention to genetically compound mice and the therapeutic applications in drug development.

  3. Tcl1 expression downregulated a distinct group of genes, including Ndp52 (show CALCOCO2 Antibodies), whose expression is very high in blastocysts but reduced in the primitive ectoderm.

  4. Data indicate that APRIL expression accelerates the onset of TCL1-driven leukemia formation mainly through TACI (show TNFRSF13B Antibodies) activation.

  5. These findings demonstrate cooperation of Tcl1 and the NF-kB pathway in the pathogenesis of aggressive chronic lymphocytic leukemia.

  6. An important role of TCL1 in activating the ER stress response in support for malignant progression of chronic lymphocytic leukemia.

  7. TCL1 and/or other genes in the TCL1 pathway are responsible for the initiation of human chronic lymphocytic leukemia.

  8. Akt (show AKT1 Antibodies) kinase activity can be inhibited by a peptide spanning the betaA strand of the proto-oncogene TCL1

  9. Tcl1 is a coactivator of Akt (show AKT1 Antibodies) signaling, in normal T- and B-cell development and function.

  10. Detailed mechanism for TCL1-augmented signaling helps explain the delayed occurrence of mature T cell expansions and leukemias despite tumorigenic TCL1 dysregulation that begins in early thymocytes.

Human T-Cell Leukemia/lymphoma 1A (TCL1A) interaction partners

  1. TCL1A is not only a useful biomarker for prognostic evaluation in stage II/III colorectal cancer patients.

  2. Our results suggest that intratumoral TCL1A+ B cells are important for controlling cervical cancer development.

  3. Our study suggests that TCL1 expression profile may have a role in the prediction of overall outcome in patient with MCL (show FH Antibodies) and call for prospective studies.

  4. We investigated TCL1 expression at the protein level in the bone marrow of a series of 59 patients with Waldenstrom macroglobulinemia: 76% of patients expressed TCL1, which appeared to be associated with a pejorative prognostic impact.

  5. Suggest miR (show MLXIP Antibodies)-181b as therapeutic target for chronic lymphocytic leukemia in the Emicro-TCL1 mouse model.

  6. High TCL1A expression is associated with chronic lymphocytic leukemia.

  7. Polymorphic genetic variations of cytochrome P450 19A1 (show CYP19A1 Antibodies) and T-cell leukemia 1A genes in the Tamil population

  8. Peptide-based TCL1-interphase mimics were potent in steric AKT (show AKT1 Antibodies) antagonization.

  9. demonstrated that miR (show MLXIP Antibodies)-3676 targets three consecutive 28-bp repeats within 3'UTR (show UTS2R Antibodies) of TCL1 and showed that miR (show MLXIP Antibodies)-3676 is a powerful inhibitor of TCL1

  10. Case Report: T-cell lymphoblastic leukemia/lymphoma with t(7;14)(p15 (show CDKN2B Antibodies);q32) [TCRgamma-TCL1A translocation] confirmed by FISH.

T-Cell Leukemia/lymphoma 1A (TCL1A) Antigen Profile

Antigen Summary

Overexpression of the TCL1 gene in humans has been implicated in the development of mature T cell leukemia, in which chromosomal rearrangements bring the TCL1 gene in close proximity to the T-cell antigen receptor (TCR)-alpha (MIM 186880) or TCR-beta (MIM 186930) regulatory elements (summarized by Virgilio et al., 1998

Alternative names and synonyms associated with T-Cell Leukemia/lymphoma 1A (TCL1A)

  • T-cell leukemia/lymphoma 1A (TCL1A) antibody
  • T cell lymphoma breakpoint 1 (Tcl1) antibody
  • T-cell leukemia/lymphoma 1A (Tcl1a) antibody
  • Tcl1 antibody
  • Tcl1a antibody

Protein level used designations for TCL1A

T-cell leukemia/lymphoma 1A , T-cell lymphoma-1 , T-cell leukemia/lymphoma protein 1A , T-cell lymphoma breakpoint 1 , TCL-1 , oncogene TCL-1 , oncogene TCL1 , protein p14 TCL1 , T-cell leukemia/lymphoma protein 1A (P14 TCL1 protein) (TCL1 oncogene) (TCL-1 protein)

506540 Bos taurus
612421 Canis lupus familiaris
741380 Pan troglodytes
21432 Mus musculus
8115 Homo sapiens
690575 Rattus norvegicus
Selected quality suppliers for anti-T-Cell Leukemia/lymphoma 1A (TCL1A) Antibodies
Did you look for something else?